BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38675214)

  • 1. Evaluation of Printability of PVA-Based Tablets from Powder and Assessment of Critical Rheological Parameters.
    Lenhart J; Pöstges F; Wagner KG; Lunter DJ
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool.
    Thakkar R; Pillai AR; Zhang J; Zhang Y; Kulkarni V; Maniruzzaman M
    Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orodispersible Polymer Films with the Poorly Water-Soluble Drug, Olanzapine: Hot-Melt Pneumatic Extrusion for Single-Process 3D Printing.
    Cho HW; Baek SH; Lee BJ; Jin HE
    Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32707862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study and Characterization of Polyvinyl Alcohol-Based Formulations for 3D Printlets Obtained via Fused Deposition Modeling.
    Ilieva S; Georgieva D; Petkova V; Dimitrov M
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drop-on-powder 3D printing of amorphous high dose oral dosage forms: Process development, opportunities and printing limitations.
    Gottschalk N; Burkard A; Quodbach J; Bogdahn M
    Int J Pharm X; 2023 Dec; 5():100151. PubMed ID: 36687376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.
    Serajuddin ATM
    ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance.
    Crișan AG; Porfire A; Ambrus R; Katona G; Rus LM; Porav AS; Ilyés K; Tomuță I
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34062744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.
    Wei C; Solanki NG; Vasoya JM; Shah AV; Serajuddin ATM
    J Pharm Sci; 2020 Apr; 109(4):1558-1572. PubMed ID: 32004538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of multiple structured extended release tablets via hot melt extrusion and dual-nozzle fused deposition modeling 3D printing.
    Zhang P; Li J; Ashour EA; Chung S; Wang H; Vemula SK; Repka MA
    Int J Pharm; 2024 Mar; 653():123905. PubMed ID: 38355075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.
    Ilyés K; Kovács NK; Balogh A; Borbás E; Farkas B; Casian T; Marosi G; Tomuță I; Nagy ZK
    Eur J Pharm Sci; 2019 Mar; 129():110-123. PubMed ID: 30610954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?
    Parulski C; Gresse E; Jennotte O; Felten A; Ziemons E; Lechanteur A; Evrard B
    Int J Pharm; 2022 Oct; 626():122157. PubMed ID: 36055443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis-Personalized Dosing and Drug Release.
    Öblom H; Zhang J; Pimparade M; Speer I; Preis M; Repka M; Sandler N
    AAPS PharmSciTech; 2019 Jan; 20(2):52. PubMed ID: 30617660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet.
    Nyavanandi D; Mandati P; Narala S; Alzahrani A; Kolimi P; Pradhan A; Bandari S; Repka MA
    Int J Pharm; 2022 Nov; 628():122283. PubMed ID: 36244563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
    Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
    Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.